Insulet (PODD) Tops Q4 EPS by 3c

Insulet (NASDAQ: PODD) reported Q4 EPS of $0.24, $0.03 better than the analyst estimate of $0.21. Revenue for the quarter came in at $369.7 million versus the consensus estimate of $332.18 million.

For earnings history and earnings-related data on Insulet (PODD) click here.

You May Also Be Interested In

• Attention Long-Term Shareholders of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY); Bloom Energy Corporation (NYSE: BE); Erasca, Inc. (NASDAQ: ERAS); and Insulet Corporation (NASDAQ: PODD): Grabar Law Offic
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15
• Important Notice to Long-Term Shareholders of Bloom Energy Corporation (NYSE: BE); Cogent Communications Holdings, Inc. (NASDAQ: CCOI); Insulet Corporation (NASDAQ: PODD); and Primoris Services Corpor